17 médecins Européens constituent le Conseil d’Administration d’ELI:
Pr. Hervé Tilly, Président
Centre Henri Becquerel
Rouen – France
Prof. Marc André
LYSA
CHU UCL Namur, Site Godinne
Université Catholique de Louvain
Yvoir – Belgique
Prof. Igor Aurer
Krotten
University of Zagreb
Zagreb – Croatie
Dr. Pascal Bilbault
LYSARC – The Lymphoma Academic Research Organisation
Centre Hospitalier Lyon Sud
Pierre-Bénite – France
www.lysarc.org
Prof. Dolores Caballero
Complejo Asistencial Universitario de Salamanca
Salamanque – Espagne
Prof. Dr. Martin Dreyling
Coordinator of the European MCL Network
Klinikum der Universität München – Medizinische Klinik III
Münich – Allemagne
www.european-mcl.net
Prof. Massimo Federico
Department of Oncology, Hematology and Diseases of the Respiratory System
University of Modena and Reggio Emilia
Centro Oncologico Modenese
Modene – Italie
Dr. Maria Gomes da Silva, Secrétaire
New University of Lisbon
Portuguese Institute of Oncology Lisbon
Lisbone – Portugal
Pr. Corinne Haioun, Trésorier
LYSA
Hôpitaux Universitaires Henri Mondor, AP-HP
Créteil – France
Prof. Marie-Josée Kersten
HOVON
AMC
Amsterdam – Pays-Bas
Prof. Eva Kimby
The Nordic Lymphoma Groupe
Karolinska Institute
Stockholm – Suède
Prof. Andrew Pettitt
NCRI Lymphoma RG
University of Liverpool
Liverpool – Royaume-Uni
Prof. Marek Trněný
Charles University, General Hospital
Prague – Republique Tchèque
Prof. Jan Walewski
The Polish Lymphoma Research Group
Maria Sklodowska-Curie National Research Institute of Oncology
Varsovie – Pologne
Prof. Emanuele Zucca
IOSI – Oncology Institute of Southern Switzerland
Bellinzona – Suisse
www.ielsg.org
